FALIPHARMA
Board
3 directors, last change in January 2026Director
since 01-01-2015
listed in the 2025 annual accounts, filed on 24-07-2026
Director (not named in the articles)
since 01-01-2015
term without a fixed end
listed in the 2025 annual accounts, filed on 24-07-2026
Director, permanent representative Céline Ruth
since 01-01-2026
listed in the 2025 annual accounts, filed on 24-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 12. Pouvoir de représentation Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit…”deed of 29-11-2021
Permanent representatives 1
Permanent representative, for Jaroline Pharma
appointed by deed of 10-02-2026
also on the board of 1 other company
Mandates through the years
4 names, the dashed line is todayJaroline Pharma
Director
Director
Scailquin Anne Marie
Director
Director
SCAILQUIN Anne Marie Ghislaine
Director (not named in the articles)
Director (not named in the articles)
Céline Ruth
Director (not named in the articles)
Director (not named in the articles)
BoardEarlierend not dated
Mandates as a list
- Jaroline Pharma
- Director, from 01-01-2015 to date
- Scailquin Anne Marie
- Director, from 01-01-2015 to date
- SCAILQUIN Anne Marie Ghislaine
- Director (not named in the articles), from 01-01-2015 to date
- Céline Ruth
- Director (not named in the articles), from 01-01-2015, no longer listed in the 2025 annual accounts
Control
100%
This company
FALIPHARMA
Equity €324,777
Profit €47,771 in 2025
Capital
- Contribution
- €19,000
- Source
- 2025 annual accounts
Articles of association
deed of 29-11-2021 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Tuesday of May at 09:00